Status:
RECRUITING
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Lead Sponsor:
Tempus AI
Conditions:
Cancer
Eligibility:
All Genders
18-99 years
Brief Summary
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition t...
Eligibility Criteria
Inclusion
- ≥18 years of age
- Willing to participate in the research
- Able to provide informed consent
- Must be diagnosed with cancer
Exclusion
- 1\. Not willing or able to have additional blood samples collected
Key Trial Info
Start Date :
June 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06207032
Start Date
June 26 2024
End Date
June 1 2029
Last Update
May 8 2025
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Alabama Oncology
Birmingham, Alabama, United States, 35233
2
PIH Health Whittier Hospital & PIH Health Physicians
Whittier, California, United States, 90605
3
Eastern CT and Hematology and Oncology Associates
Norwich, Connecticut, United States, 06360
4
Cancer Specialists of North Florida
Jacksonville, Florida, United States, 32256